Most adults lose approximately 10-15% of their body weight on semaglutide 2.4 mg (Wegovy) over 68 weeks. In the pivotal STEP 1 clinical trial, participants lost an average of 14.9% of their body weight, which translated to roughly 33 pounds for the average participant in that study.

What the Clinical Trials Show

Semaglutide for weight management has been studied extensively across the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program. These trials provide the most reliable data on expected weight loss outcomes.

STEP 1: The Landmark Trial

The STEP 1 trial enrolled 1,961 adults with obesity (BMI of 30+) or overweight (BMI of 27+) with at least one weight-related condition. All participants received lifestyle counseling in addition to either semaglutide 2.4 mg or placebo. Key results at 68 weeks:

• Average weight loss with semaglutide: 14.9% of body weight
• Average weight loss with placebo: 2.4% of body weight
• One-third of semaglutide participants lost 20% or more of their body weight
• Over 86% of participants lost at least 5% of their body weight

Results Across Other STEP Trials

The broader STEP program confirmed these findings across different populations:

• STEP 2 (patients with type 2 diabetes): Average weight loss of 9.6% at 68 weeks. Weight loss tends to be more modest in patients with diabetes.
• STEP 3 (intensive behavioral therapy added): Average weight loss of 16.0%, showing that combining semaglutide with structured lifestyle programs enhances results.
• STEP 4 (withdrawal study): Participants who continued semaglutide maintained their weight loss, while those switched to placebo regained about two-thirds of what they had lost.
• STEP 5 (2-year data): Average weight loss of 15.2% at 104 weeks, demonstrating that results are sustained with continued use.

Weight Loss Timeline

Weight loss with semaglutide follows a predictable pattern:

• Weeks 1-4 (2.5 mg dose): Minimal weight loss during the initial titration phase, typically 1-3 pounds.
• Weeks 5-16 (dose escalation from 0.5 mg to 1.7 mg): Weight loss accelerates as the dose increases. Most people see 3-5% of body weight lost by this point.
• Weeks 17-68 (maintenance dose of 2.4 mg): Steady weight loss continues, with the most significant results appearing between months 4 and 12.
• After 68 weeks: Weight loss typically plateaus, and the focus shifts to weight maintenance.

What That Looks Like in Pounds

To put the percentages in practical terms:

• A person starting at 200 pounds might expect to lose roughly 25-30 pounds
• A person starting at 250 pounds might expect to lose roughly 30-38 pounds
• A person starting at 300 pounds might expect to lose roughly 38-45 pounds

These are averages. Individual results vary widely based on several factors.

Factors That Affect Your Results

Several variables influence how much weight you will lose on semaglutide:

• Starting weight: People with higher starting weights tend to lose more total pounds but may lose a similar percentage of body weight.
• Diet and exercise: Semaglutide works best when combined with a reduced-calorie diet and increased physical activity. Trial participants all received lifestyle counseling.
• Diabetes status: Patients with type 2 diabetes typically lose less weight on semaglutide (around 10% vs. 15%), likely due to metabolic differences.
• Dose tolerance: Some patients cannot tolerate the full 2.4 mg dose due to side effects and stay on a lower dose, which generally produces less weight loss.
• Adherence: Consistent weekly injections and sustained lifestyle changes are essential for optimal results.
• Genetics and metabolism: Individual biological variability means some people are stronger responders to GLP-1 therapy than others.

What to Consider

Clinical trial averages represent group-level data. Some individuals lose significantly more than 15%, while others lose less than 5%. About 14% of participants in STEP 1 did not achieve at least 5% weight loss. Setting realistic expectations with your physician helps avoid frustration and supports long-term success.

Weight loss is not linear. Plateaus are normal, and weekly fluctuations are expected. Measuring progress over months rather than weeks gives a more accurate picture. Your physician may track additional health markers, such as blood pressure, A1C, and waist circumference, to assess the full benefit of treatment.

Semaglutide is intended as a long-term therapy. Discontinuing the medication typically results in weight regain, so discussing a sustainable treatment plan with your provider is important.

Related Questions

How fast do you lose weight on semaglutide?

Weight loss begins during the titration phase and accelerates once you reach the therapeutic dose. Most patients see noticeable results within 8-12 weeks. The fastest rate of loss typically occurs between months 3 and 9, after which the rate gradually slows as you approach a new baseline weight.

Will I regain weight if I stop semaglutide?

Studies show that most people regain a significant portion of lost weight within one year of stopping semaglutide. The STEP 4 trial found that participants regained about two-thirds of their weight loss after discontinuing the medication. This is why most physicians recommend continued treatment or a structured transition plan.

Does semaglutide work for everyone?

Semaglutide produces meaningful weight loss (5% or more of body weight) in approximately 85% of users in clinical trials. The remaining 15% may not respond as strongly due to genetic, metabolic, or behavioral factors. Your physician can assess your response and consider alternatives if semaglutide is not producing expected results after several months.

Is the weight loss from semaglutide mostly fat?

The majority of weight lost on semaglutide is fat mass, but some lean mass loss also occurs. Studies using body composition imaging suggest that roughly 60-75% of weight lost is fat mass. Adequate protein intake (at least 1.0-1.2 g per kg of body weight daily) and resistance training can help preserve muscle during treatment.

Start Your Semaglutide Journey with FormBlends

FormBlends connects you with licensed physicians who specialize in GLP-1 therapy for weight management. Your personalized treatment plan includes medical evaluation, proper dose titration, and ongoing support to maximize your results. Start your consultation today to see if semaglutide is right for you.